Abstract: Described herein are certain crystalline forms of Compound 3, as well as pharmaceutical compositions employing the crystalline forms. Also provided are particles (e.g., nanoparticles) comprising such crystalline forms or pharmaceutical compositions. In certain examples, the particles are mucus penetrating particles (MPPs). The present invention further relates to methods of treating or preventing diseases using crystalline forms or pharmaceutical compositions.

Abstract: Tether tensioning instruments, such as instruments used to tension and/or lock a tether about a spinal feature to assist in spinal fixation, and related methods and systems. In some embodiments, the instrument may comprise a handle, a tensioner base coupled with the handle, at least a portion thereof being movably coupled to the handle, and a tether coupling member coupled with the tensioner base and configured to fixedly engage a tether. The instrument may further comprise a tensioner tip movably coupled with the tensioner base, wherein at least a portion of the tensioner base is biased away from the tensioner tip, and wherein the instrument is configured to allow for step-wise movement of the tensioner tip away from the tensioner base to increase tension between the tether and an element of the spinal fixation system.

Abstract: Provided herein is a compound, 1-(4-(3-amino-[1,2,3]triazolo[1,5-a]pyridin-4-yl)phenyl)-3-(3-chlorophenyl)urea, pharmaceutical compositions thereof, and crystal forms thereof. Also provided are particles (e.g., nanoparticles) comprising the compound, and pharmaceutical compositions thereof, that are mucus penetrating. Also provided herein are methods and kits for using the compound, and pharmaceutical compositions thereof, for treating and/or preventing diseases associated with abnormal or pathological angiogenesis and/or aberrant signaling of a growth factor (e.g., vascular endothelial growth factor (VEGF)), such as proliferative diseases (e.g., cancers, benign neoplasms, inflammatory diseases, autoimmune diseases) and ocular diseases (e.g., macular degeneration, glaucoma, diabetic retinopathy, retinoblastoma, edema, uveitis, dry eye, blepharitis, and post-surgical inflammation) in a subject in need thereof.

Abstract: A calling user initiates a telephonic communication with a receiving user by dialing a phone number of the receiving user in his or her address book. The communication is transmitted from the calling user's device to the receiving user's device through a network that is not using Internet protocol or Internet-based, e.g., Transmission Control Protocol (TCP), Internet Protocol (IP), TCP-IP, or Voice over Internet Protocol (VoIP). After a number of notifications has passed on the receiving user's device and the receiving user is not able to answer the telephonic communication, a local voicemail recorder will be activated to record and store the telephonic communication for later retrieval by the receiving user. The stored communication is identifier by a sequence of string containing at least one of a name, a telephone number, a storage location, a date-time attribute, and a duration associated with the stored communication.

Abstract: In one example, a system for bypass switch control includes a controller coupled to a number of backup power modules and to a number of bypass switches that correspond to each of the number of backup power modules, wherein the controller activates a bypass switch when a corresponding backup power module is deactivated.

Abstract: In one example, a system for parallel output of backup power modules includes a first backup power module coupled to an input and a first output of an enclosure, a second backup power module coupled to the input and a second output of the enclosure, wherein the second backup power module is coupled in parallel with the first backup power module, and a switch coupling the first backup power module and the first output of the enclosure to the second output of the enclosure.

Abstract: Example implementations relate to concurrent alternating-current and direct-current. In one example, a device comprises a power module connected to a first power outlet, the power module connected to a second power outlet, and a controller to the power module to concurrently provide alternating-current (AC) power to the first power outlet and direct-current (DC) power to the second power outlet by switching a transistor including switching circuitry in response to an absence of AC input power to the device.

Abstract: Provided herein is a compound, 1-(4-(3-amino-[1,2,3]triazolo[1,5-a]pyridin-4-yl)phenyl)-3-(3-chlorophenyl)urea, pharmaceutical compositions thereof, and crystal forms thereof. Also provided are particles (e.g., nanoparticles) comprising the compound, and pharmaceutical compositions thereof, that are mucus penetrating. Also provided herein are methods and kits for using the compound, and pharmaceutical compositions thereof, for treating and/or preventing diseases associated with abnormal or pathological angiogenesis and/or aberrant signaling of a growth factor (e.g., vascular endothelial growth factor (VEGF)), such as proliferative diseases (e.g., cancers, benign neoplasms, inflammatory diseases, autoimmune diseases) and ocular diseases (e.g., macular degeneration, glaucoma, diabetic retinopathy, retinoblastoma, edema, uveitis, dry eye, blepharitis, and post-surgical inflammation) in a subject in need thereof.

Abstract: In one example, a system for parallel output of backup power modules includes a first backup power module coupled to an input and a first output of an enclosure, a second backup power module coupled to the input and a second output of the enclosure, wherein the second backup power module is coupled in parallel with the first backup power module, and a switch coupling the first backup power module and the first output of the enclosure to the second output of the enclosure.

Abstract: Example implementations relate to concurrent alternating-current and direct-current. In one example, a device comprises a power module connected to a first power outlet, the power module connected to a second power outlet, and a controller to the power module to concurrently provide alternating-current (AC) power to the first power outlet and direct-current (DC) power to the second power outlet by switching a transistor including switching circuitry in response to an absence of AC input power to the device.

Abstract: A power storage and generation system is modular, portable, stackable, electrically connectable, interchangeable, and customizable with respect to interconnections among one another. The electrical connections are arranged in such a manner that they are not exposed to the user when in use, thus preventing accidental short circuits or electrical shocks. The power storage and generation systems can be used together or separately to provide both D/C power then converts to A/C power supply for electrical equipment at remote locations. Different configurations allow for the adaptation of the system to different voltage and amperage requirements for various applications.

Abstract: A method of gaming comprising: selecting in at least one game round a plurality of symbols for display to a player in a set of display positions; modifying the displayed symbols copying each symbol in an original subset of the display positions to at least one clone subset of the display positions which is identical to or laterally displaced from the original subset, in response to determining that a subset of the symbols should be cloned; and determining an outcome based on the modified symbols.

Abstract: Techniques for providing an uninterruptible power supply are disclosed. An example system includes three single-phase Uninterruptible Power Supplies (UPSs) and an adapter. The adapter is to receive three-phase AC power, and separate the three-phase AC power into three separate single-phase outputs. Each single-phase output is coupled to an input of one of the three single-phase UPSs. An output of each one of the single-phase UPSs is coupled to one of three single-phase inputs of the adapter, and the adapter is to combine the three single-phase inputs into a single three-phase output.

Abstract: According to an example, a battery is charged using a charge voltage based on a present state of charge of the battery and a present ambient temperature of the battery. Additionally, the charge voltage may be based on the present state of charge of the battery, the present ambient temperature of the battery, and an age of the battery. The charge voltage may be retrieved from a lookup table that includes a plurality of reference charge voltage values at which to charge the battery for different ambient temperatures, different states of charge, or different ages of the battery.

Abstract: Described herein are crystalline forms of Compound 1 useful for the prevention and treatment of angiogenic ocular conditions; methods of treating a disease comprising; processes for preparing; and kits comprising, the same.

Abstract: Described herein are systems and methods from delivering prosthetic devices, such as prosthetic heart valves, through the body and into the heart for implantation therein. The prosthetic devices delivered with the delivery systems disclosed herein are, for example, radially expandable from a radially compressed state mounted on the delivery system to a radially expanded state for implantation using an inflatable balloon of the delivery system. Exemplary delivery routes through the body and into the heart include transfemoral routes, transapical routes, and transaortic routes, among others.

Abstract: Described herein are certain crystalline forms of Compound 3, as well as pharmaceutical compositions employing the crystalline forms. Also provided are particles (e.g., nanoparticles) comprising such crystalline forms or pharmaceutical compositions. In certain examples, the particles are mucus penetrating particles (MPPs). The present invention further relates to methods of treating or preventing diseases using crystalline forms or pharmaceutical compositions.

Abstract: Described herein are crystalline forms of Compound 1 useful for the prevention and treatment of angiogenic ocular conditions; methods of treating a disease comprising; processes for preparing; and kits comprising, the same.